DHR · 10-Q · 2026Q3 · Full report
Guidance / Outlook
DANAHER CORP /DE/ · 2026-10-21 · Importance 40 · Surprise 42 · In source text
Danaher cautioned that demand for respiratory testing products may be affected by the severity of the upcoming respiratory season and by customer purchases made in preparation for that season. The Company said these factors could adversely affect demand for respiratory tests during the remainder of 2026. The uncertainty specifically concerns the Diagnostics segment’s molecular diagnostics business, where respiratory-test demand declined year over year while non-respiratory testing increased. No quantitative revenue or margin guidance was provided in this section.
Key facts
- The Company expects its effective tax rate for the full year of 2026 to be approximately 17.0% based on its projected mix of earnings. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | unclear | probable | — | The Company expects its effective tax rate for the full year of 2026 to be approximately 17.0% based on its projected mix of earnings. |